{"id":"https://openalex.org/W2008161586","doi":"https://doi.org/10.4155/tde.10.38","title":"Carrier-based Intralymphatic Cisplatin Chemotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck","display_name":"Carrier-based Intralymphatic Cisplatin Chemotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck","publication_year":2010,"publication_date":"2010-08-01","ids":{"openalex":"https://openalex.org/W2008161586","doi":"https://doi.org/10.4155/tde.10.38","mag":"2008161586","pmid":"https://pubmed.ncbi.nlm.nih.gov/21339844","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3039877"},"language":"en","primary_location":{"id":"doi:10.4155/tde.10.38","doi":"https://doi.org/10.4155/tde.10.38","is_oa":false,"landing_page_url":"https://doi.org/10.4155/tde.10.38","pdf_url":null,"source":{"id":"https://openalex.org/S89829989","display_name":"Therapeutic Delivery","issn_l":"2041-5990","issn":["2041-5990","2041-6008"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Delivery","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3039877","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103074573","display_name":"Shuang Cai","orcid":"https://orcid.org/0000-0003-2976-6918","observed_orcids":["https://orcid.org/0000-0003-2976-6918"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuang Cai","raw_affiliation_strings":["Department of Pharmaceutical Chemistry , University of Kansas, Lawrence, KS 66047, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry , University of Kansas, Lawrence, KS 66047, USA","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026609668","display_name":"Yumei Xie","orcid":"https://orcid.org/0000-0002-4951-1296","observed_orcids":["https://orcid.org/0000-0002-4951-1296"]},"institutions":[{"id":"https://openalex.org/I142606810","display_name":"Pacific Northwest National Laboratory","ror":"https://ror.org/05h992307","country_code":"US","type":"facility","lineage":["https://openalex.org/I1325736334","https://openalex.org/I1330989302","https://openalex.org/I142606810","https://openalex.org/I39565521"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yumei Xie","raw_affiliation_strings":["The Pacific Northwest National Laboratory, Richland, WA 99354, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Pacific Northwest National Laboratory, Richland, WA 99354, USA","institution_ids":["https://openalex.org/I142606810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027225356","display_name":"Neal M. Davies","orcid":"https://orcid.org/0000-0002-7050-1471","observed_orcids":["https://orcid.org/0000-0002-7050-1471"]},"institutions":[{"id":"https://openalex.org/I72951846","display_name":"Washington State University","ror":"https://ror.org/05dk0ce17","country_code":"US","type":"education","lineage":["https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal M Davies","raw_affiliation_strings":["Washington State University, Pullman, WA 99164, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington State University, Pullman, WA 99164, USA","institution_ids":["https://openalex.org/I72951846"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057675169","display_name":"Mark Steven Cohen","orcid":"https://orcid.org/0000-0002-2517-0757","observed_orcids":["https://orcid.org/0000-0002-2517-0757"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark S Cohen","raw_affiliation_strings":["University of Kansas Medical Center\r          Kansas City\r          KS\r          66160\r          USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kansas Medical Center\r          Kansas City\r          KS\r          66160\r          USA","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046407367","display_name":"Marcus Laird Forrest","orcid":"https://orcid.org/0000-0002-0288-6138","observed_orcids":["https://orcid.org/0000-0002-0288-6138"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Laird Forrest","raw_affiliation_strings":["Department of Pharmaceutical Chemistry University of Kansas Lawrence\r          KS\r          66047\r          USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry University of Kansas Lawrence\r          KS\r          66047\r          USA","institution_ids":["https://openalex.org/I146416000"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9364,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.68410661,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"1","issue":"2","first_page":"237","last_page":"245"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.019999999552965164,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.6349999904632568},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8709999918937683},{"id":"https://openalex.org/keywords/lymphatic-drug-delivery","display_name":"lymphatic drug delivery","score":0.7580000162124634},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-survival","display_name":"drug retention","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7162837386131287},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7116389870643616},{"id":"https://openalex.org/C3018411727","wikidata":"https://www.wikidata.org/wiki/Q3867488","display_name":"Head and neck","level":2,"score":0.6726078987121582},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6501152515411377},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.5381439924240112},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5212074518203735},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.5155456066131592},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.4374789595603943},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42757949233055115},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3204004168510437},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.212863951921463},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.17769432067871094}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006820","descriptor_name":"Hyaluronic Acid","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006820","descriptor_name":"Hyaluronic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008208","descriptor_name":"Lymphatic System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008208","descriptor_name":"Lymphatic System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008208","descriptor_name":"Lymphatic System","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.4155/tde.10.38","doi":"https://doi.org/10.4155/tde.10.38","is_oa":false,"landing_page_url":"https://doi.org/10.4155/tde.10.38","pdf_url":null,"source":{"id":"https://openalex.org/S89829989","display_name":"Therapeutic Delivery","issn_l":"2041-5990","issn":["2041-5990","2041-6008"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Delivery","raw_type":"journal-article"},{"id":"pmid:21339844","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21339844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic delivery","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3039877","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3039877","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Ther Deliv","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3039877","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3039877","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Ther Deliv","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G229183575","display_name":null,"funder_award_id":"P20-RR015563","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G3117117730","display_name":"Targeted polymeric nanocarriers for combination therapy of metastatic prostate ca","funder_award_id":"R21CA132033","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G343181842","display_name":"Center for Cancer Experimental Therapeutics","funder_award_id":"5p20rr015563-08","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W43327592","https://openalex.org/W179726730","https://openalex.org/W1594249896","https://openalex.org/W1967006692","https://openalex.org/W1987405720","https://openalex.org/W1995348902","https://openalex.org/W2001993127","https://openalex.org/W2008287191","https://openalex.org/W2018503571","https://openalex.org/W2044978841","https://openalex.org/W2052202390","https://openalex.org/W2057609290","https://openalex.org/W2063653843","https://openalex.org/W2067986789","https://openalex.org/W2083307422","https://openalex.org/W2095834627","https://openalex.org/W2102393895","https://openalex.org/W2121468544","https://openalex.org/W2139333988","https://openalex.org/W2141747788","https://openalex.org/W2143013400","https://openalex.org/W2148507283","https://openalex.org/W2155633466","https://openalex.org/W2159695989","https://openalex.org/W2164122108"],"related_works":["https://openalex.org/W7095873503","https://openalex.org/W2122741198","https://openalex.org/W2164122108","https://openalex.org/W2383884527","https://openalex.org/W1986270653","https://openalex.org/W1975991586","https://openalex.org/W2259254505","https://openalex.org/W1965832941","https://openalex.org/W1997559389","https://openalex.org/W2208224814"],"abstract_inverted_index":{"BACKGROUND:":[0],"Since":[1],"head":[2],"and":[3,35,114],"neck":[4],"squamous":[5],"cell":[6],"carcinoma":[7],"(HNSCC)":[8],"preferentially":[9],"metastasizes":[10],"to":[11,57,106],"the":[12,17,42,59,62,75,79,91,108],"locoregional":[13],"lymphatics,":[14],"treatment":[15,43,81],"of":[16,44,55,61,74],"tumor-draining":[18],"cervical":[19],"lymph":[20],"nodes":[21],"is":[22],"paramount.":[23],"RESULTS:":[24],"We":[25,47],"developed":[26,49],"a":[27],"hyaluronan-cisplatin":[28],"(HA-Pt)":[29],"nanoconjugate":[30],"with":[31,90],"prolonged":[32],"lymphatic":[33],"retention":[34,115],"greatly":[36,85],"improved":[37],"tumor":[38],"tissue":[39],"deposition":[40],"for":[41,72,110],"metastatic":[45,52],"HNSCC.":[46],"also":[48],"an":[50],"orthotopic":[51],"xenograft":[53],"model":[54],"HNSCC":[56,64,87],"examine":[58],"efficacy":[60],"nanoconjugate.":[63],"(1/week":[65],"x":[66],"3":[67],"weeks)":[68],"were":[69],"completely":[70],"cured":[71],"57%":[73],"female":[76],"mice":[77],"in":[78],"HA-Pt":[80],"group,":[82],"which":[83],"demonstrated":[84],"hindered":[86],"progression":[88],"compared":[89],"standard":[92],"cisplatin":[93],"therapy":[94],"(p":[95],"<":[96],"0.05).":[97],"CONCLUSION:":[98],"With":[99],"this":[100],"insight,":[101],"we":[102],"will":[103],"be":[104],"able":[105],"optimize":[107],"carriers":[109],"better":[111],"uptake,":[112],"penetration":[113],"within":[116],"cancer":[117],"cells.":[118]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}